Principal Financial Group
MRTX

Principal Financial Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Principal Financial Group’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,784
Closed -$634K – 2534
2023
Q4 		$634K Sell
10,784
-567
-5% -$33.3K ﹤0.01% 1909
2023
Q3 		$494K Buy
11,351
+355
+3% +$15.5K ﹤0.01% 1953
2023
Q2 		$397K Sell
10,996
-1,176
-10% -$42.5K ﹤0.01% 2005
2023
Q1 		$453K Sell
12,172
-310
-2% -$11.5K ﹤0.01% 1985
2022
Q4 		$566K Buy
12,482
+1,192
+11% +$54K ﹤0.01% 1947
2022
Q3 		$789K Buy
11,290
+499
+5% +$34.9K ﹤0.01% 1875
2022
Q2 		$724K Buy
10,791
+703
+7% +$47.2K ﹤0.01% 1980
2022
Q1 		$829K Sell
10,088
-352
-3% -$28.9K ﹤0.01% 2015
2021
Q4 		$1.53M Sell
10,440
-3,643
-26% -$535K ﹤0.01% 1903
2021
Q3 		$2.49M Sell
14,083
-1,848
-12% -$327K ﹤0.01% 1831
2021
Q2 		$2.57M Sell
15,931
-40,812
-72% -$6.59M ﹤0.01% 1852
2021
Q1 		$9.72M Buy
56,743
+32,773
+137% +$5.61M 0.01% 1396
2020
Q4 		$5.27M Buy
23,970
+876
+4% +$192K ﹤0.01% 1544
2020
Q3 		$3.84M Sell
23,094
-613
-3% -$102K ﹤0.01% 1560
2020
Q2 		$2.71M Buy
23,707
+6,459
+37% +$738K ﹤0.01% 1627
2020
Q1 		$1.33M Buy
17,248
+2,364
+16% +$182K ﹤0.01% 1692
2019
Q4 		$1.92M Buy
14,884
+52
+0.4% +$6.7K ﹤0.01% 1732
2019
Q3 		$1.16M Buy
14,832
+857
+6% +$66.7K ﹤0.01% 1808
2019
Q2 		$1.44M Buy
13,975
+1,416
+11% +$146K ﹤0.01% 1785
2019
Q1 		$921K Buy
+12,559
New +$921K ﹤0.01% 1837
2018
Q4 		– Sell
-4,473
Closed -$211K – 2326
2018
Q3 		$211K Buy
4,473
+222
+5% +$10.5K ﹤0.01% 2157
2018
Q2 		$210K Buy
+4,251
New +$210K ﹤0.01% 2156